October/November #167 : ADAP Update - by Trenton Straube

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

From Mice Into Men

The Doctor Is In




At the End of Your Rope?

A Slippery Slope?

Senior Strength




POZ Q&A: Jeffrey Crowley

Standing Against Stigma

The Stigma Index

ADAP Update

Get Your Game On

It’s Everyone’s Business

Pozarazzi




Editor's Letter

Letters

No Hate



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


Scroll down to comment on this story.


email print

October / November 2010


ADAP Update

by Trenton Straube

Waiting lists may evaporate—for a few months—but the crisis ain’t over.

First the good news: As waiting lists in 13 states for AIDS Drug Assistance Programs (ADAPs) skyrocketed in July to a record 2,359 people, the Obama administration allotted $25 million in emergency funds to address the crisis. The money is expected to reduce—if not eliminate—waiting lists for ADAP, which furnishes HIV-related meds and extends insurance to those in need. Plus, Congressional subcommittees are recommending another $25 million for ADAP in fiscal year 2011, which begins April 1.

Now the bad news: It’s a temporary reprieve, at best. “I don’t think it’ll be long before we see waiting lists creep up again,” says Ann Lefert of the National Alliance of State and Territorial Directors (NASTAD). Florida, for example, is expected to keep adding about 400 people per month.

Although some folks on waiting lists scramble together access to treatment, others do go off meds, which can lead to drug resistance and fewer treatment options for the future. What’s more, adds Carl Schmid of The AIDS Institute, “Waiting lists are the tip of the iceberg.” Each state sets up its own ADAP eligibility requirements and benefits, though the money comes from the federal Ryan White program. States generally protect ADAP, Schmid says, so if a state cuts its ADAP and places residents on waiting lists, that means it has already slashed HIV prevention efforts, tightened ADAP eligibility and reduced the meds the program covers.

A June NASTAD report spells out why we’re in this ADAP mess. Demand is growing because more people are unemployed and losing health insurance. ADAP funds are shrinking because of state and federal fiscal crises. (Last year, states contributed 14 percent of the total ADAP national budget, which marks a 34 percent decrease from the previous year, and the federal government supplied 49 percent of the funds—the first time since 1997 that its earmark dipped below 50.) In addition, the nation’s efforts to test more people have led to more diagnoses. And then there’s the fact that HIV meds are working—which means more people are living longer and taking meds.

Tomorrow’s news: Health care reform will alleviate many problems—but that doesn’t fully kick in until 2014. For now, pharmaceutical companies are offering rebates and reduced prices to ADAP. Their rebates accounted for 31 percent of the 2009 national ADAP budget, a huge leap from 7 percent a decade earlier. Unfortunately, the newly announced National HIV/AIDS Strategy offers little in terms of resources. As both Lefert and Schmid say, if advocates don’t convince Congress to bolster HIV/AIDS money, yesterday’s news will repeat itself as tomorrow’s headlines.            

Search: ADAP, waiting lists, The AIDS Institute, National HIV/AIDS Strategy, NASTAD


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    CuteBoyinQns
    Jackson Heights
    New York


    usuallyhappy
    Palm Springs
    California


    usuallyhappy
    Palm Springs
    California


    jap022964
    el dorado
    Arkansas
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Will decriminalizing injection drug use help end the global HIV epidemic?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.